{"id":"W2603924317","doi":"10.1111/bjh.14569","title":"A phase 1 trial of temsirolimus and intensive re-induction chemotherapy for 2nd or greater relapse of acute lymphoblastic leukaemia: a Children's Oncology Group study (ADVL1114)","year":2017,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"PI3K/AKT/mTOR signaling in cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":40,"is_retracted":false,"has_abstract":true,"ca_institutions":"Hospital for Sick Children","funders":"National Institutes of Health; Leukemia and Lymphoma Society; National Cancer Institute; Rally Foundation","keywords":"Temsirolimus; Medicine; Mucositis; Internal medicine; Toxicity; Regimen; Induction chemotherapy; Sirolimus; Clinical endpoint; Chemotherapy; Gastroenterology; Oncology; Clinical trial; PI3K/AKT/mTOR pathway; Discovery and development of mTOR inhibitors; Biology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005465056,0.00019399,0.0009781725,0.0001108376,0.0001354545,0.0000287492,0.0003653082,0.0003502063,0.00001732811],"category_scores_gemma":[0.0007281057,0.000182588,0.0002072157,0.00004019957,0.0004517874,0.00002227036,0.0001025813,0.0001955234,2.089282e-7],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00004315626,"about_ca_system_score_gemma":0.0002601673,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00009095475,"about_ca_topic_score_gemma":0.000101206,"domain_scores_codex":[0.9982083,0.0001674073,0.000886109,0.0003275917,0.0001557037,0.0002549233],"domain_scores_gemma":[0.9971172,0.00007005499,0.00169453,0.0003457121,0.0006765574,0.00009591532],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.4163066,0.006817768,0.005708789,0.0003196376,0.008223558,0.007283151,0.001589653,0.00001611887,0.4756882,0.00005253743,0.01293622,0.06505784],"study_design_scores_gemma":[0.45748,0.1251374,0.005200957,0.0006583366,0.002044624,0.1918545,0.00123432,0.0000470732,0.2131349,0.0004905116,0.001990749,0.0007265728],"study_design_candidate":"randomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9967797,0.0006195951,0.000709998,0.0002195473,0.0008084169,0.0007617499,0.00007612121,0.000003462966,0.00002134621],"genre_scores_gemma":[0.9977774,0.000682224,0.000849148,0.0001115266,0.0004320541,0.00003787618,0.00001255856,0.00003556161,0.00006167224],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.2625533,"threshold_uncertainty_score":0.7445722,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.02386398180393254,"score_gpt":0.336079125056828,"score_spread":0.3122151432528955,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}